Stock Rating Downgrade
The Value Trend Rating for GSK plc (NYSE: GSK) weakened of late from C to D reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are included in our next report.
Recent Price Action
On 5/20/24, GSK plc (NYSE: GSK) stock declined slightly by -0.9%, closing at $44.59. Moreover, this decline was accompanied by unusually high trading volume at 170% of normal. Relative to the market the stock has been strong over the last nine months but has declined -1.1% during the last week.
Current PriceTarget Research Rating
GSK’s future returns on capital are forecasted to be above the cost of capital. Accordingly, the company is expected to continue to be a major Value Builder.
GSK plc has a current Value Trend Rating of D (Negative). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. GSK plc has a very low Appreciation Score of 13 but a good Power Rating of 73, leading to the Negative Value Trend Rating.
Be the first to comment